Educational research tool. Not investment advice. You are responsible for your own trading decisions.

Verdix.
← All analysis

Kongsberg Gruppen ASA (KOG)

Verdict history · KOG

Every call Verdix has made on KOG.

While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.

Click any date below to read that write-up

WaitBalanced· Aug 22, 2026

Since the prior WAIT call at 336.7, the stock drifted 6.5% lower into the 304–340 coil without triggering either boundary condition — the value-entry zone near 250–270 never materialized and the breakout above 340.55 never confirmed. The panel shifted from zero bullish voices to one (The Activist Catalyst), but the arithmetic still lands at BALANCED: the discount to intrinsic value has widened just enough to attract one value-oriented voice without convincing the remaining five that the margin of safety is sufficient.

See methodology for how verdicts are produced. Full track record →

The panel’s split verdict on KOG — and where they disagree.

BalancedMEDIUM confidence

The case for and against roughly balance — no clear edge at today's price.

OSL · Industrials · 2026-08-22 · analysis, not advice

Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.

Verdict

Balanced

MEDIUM confidence

Why

Kongsberg Gruppen sits in a 304–340 NOK holding pattern as six archetypal investors weigh a world-class defence franchise (43.7% ROIC, NOK 157.5B backlog) against a stretched valuation (33.8x forward earnings). The panel lands at BALANCED: one bullish voice sees a 25% discount to intrinsic value, while five cautious voices demand a wider margin of safety before committing fresh capital to an otherwise exceptional business.

Level to watch

Key support 304.33

−3.4% from 314.9

Next catalyst

Breakout level to confirm the turn: A weekly close above 340.55 with expanding volume flips the call decisively, confirming the coil resolves upward and the Stage 2 uptrend resumes.

The panel's take

Verdict: BALANCED · Conviction: MEDIUM · Last price: 314.9 · Changed from WAIT

Panel: 1 Bullish · 4 Neutral · 1 Bearish → BALANCED

What changed since 2026-08-15:

  • Price: 336.7 → 314.9 (-6.47%)
  • Panel: 0 of 6 → 1 of 6 now Bullish — composition also changed: added The Activist Catalyst, The Asymmetric Bargainer; removed The Macro Opportunist, The Quality Rationalist
  • Trigger: A weekly close above 340.55 with expanding volume flips this to BUY (coil breakout confirmed, Stage 2 uptrend resuming). A weekly close below 304.33 flips this to SELL — the 61.8% Fibonacci giving way confirms the Stage 2 structure has broken and the correction has further to run.
  • Verdict: WAIT → BALANCED

Since the prior WAIT call at 336.7, the stock drifted 6.5% lower into the 304–340 coil without triggering either boundary condition — the value-entry zone near 250–270 never materialized and the breakout above 340.55 never confirmed. The panel shifted from zero bullish voices to one (The Activist Catalyst), but the arithmetic still lands at BALANCED: the discount to intrinsic value has widened just enough to attract one value-oriented voice without convincing the remaining five that the margin of safety is sufficient.

The prior WAIT trigger (weekly close above 340.55 or pullback to 250–270) has not fired — price drifted from 336.7 to 314.9, nearer fair value but still above the value-entry zone the bears and neutrals demand. Every cautious voice, including The Moat Compounder's outright bear call, acknowledges the business quality (43% ROIC, NOK 157.5B backlog, wide moat) and objects purely on valuation. The Activist Catalyst's lone bull case rests on the same quality at a ~25% discount to his intrinsic-value range. With the stock compressing into a 304–340 coil and no catalyst breaking either way, selling a world-class franchise makes no sense, but neither does buying without a margin of safety. The arithmetic — 1 Bullish, 4 Neutral, 1 Bearish — lands at BALANCED: keep what you own, no fresh capital until a boundary gives way.

Key levels

Key levels · KOG

NOK · as of 2026-08-22
Analyst consensus 387.78
R3402
+27.7%
R2340.55
+8.1%
R1327.75
+4.1%
S1304.33
−3.4%
S2298.84
−5.1%
S3287.07
−8.8%
NOW
314.9

Analyst consensus target 387.78 NOK · range 280554

Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.

Key support at 304.33 is the weekly 61.8% Fibonacci retracement of the 228.50–427 range; a breakdown would target monthly EMA20 at 298.84 and the monthly 38.2% retracement at 287.07 — the zone where value-oriented voices including The Moat Compounder have said they would turn constructive. Key resistance at 327.75 (weekly 50% Fibonacci) and the 339.90–340.55 zone, where the monthly 23.6% Fibonacci converges with weekly horizontal resistance that has capped every rally attempt since the 427 high was posted in late 2025. The analyst consensus target of 387.78 sits above both near-term resistance levels, consistent with the bull case but priced only on a confirmed breakout.

What legendary investors think

We ran Kongsberg Gruppen ASA past a panel of 6 legendary investors' frameworks.

The panel · 6 investors

🟢
1
Bullish
4
Neutral
🔴
1
Bearish
The GARP OperatorGrowth (GARP) NeutralMed

Signal: The PEG of 1.73 is not a bargain, but a record NOK 157.5B backlog covering 4x trailing revenue gives the kind of multi-year visibility that justifies paying a small premium for a company still compounding EPS at 19.5%. Conviction: Conviction is held back because at 33.8x forward earnings the stock is priced for near-flawless execution, and the Q2 margin compression in Defence Systems (19.6% to 17.7%) shows delivery risk is real.

The Intrinsic-Value ModelerValuation/DCF NeutralLow

Signal: Base-case DCF points to fair value around NOK 350, an 11% upside, but the wide analyst target dispersion (280–554 NOK) with a median of only 335 reveals genuine uncertainty about whether the company can convert its backlog into margin-accretive earnings. Conviction: The gap between fair value and price sits within the margin of error for a defence stock with this degree of execution and political risk, so conviction on a directional call remains low.

The Moat CompounderValue/Quality/Moat🔴 BearishMed

Signal: The business earns a 43.7% ROIC with a net cash balance sheet and a wide, durable moat, yet the FCF yield of 2.1% sits well below the 4.7% on 10-year Treasuries, offering no margin of safety at the current quote. Conviction: Bearish conviction is tempered by the reality that this is a genuinely wonderful franchise — the 43.7% ROIC and NOK 157.5B backlog mean the moat widens with every passing quarter, and betting against a compounding machine like this carries its own risk.

The Asymmetric BargainerContrarian/Deep Value NeutralLow

Signal: The Dhandho test passes only 2 of 4 questions — simple business and substantial upside are clear, but at 51.9x trailing earnings with a 20–30% drawdown plausible on a trough earnings miss, limited downside protection is absent and the odds are not yet favorable. Conviction: Without insider buying or superinvestor positioning data to confirm that smart money sees the same optionality, the setup remains a marginal pitch rather than a fat one.

The Forensic SkepticContrarian/Forensic NeutralLow

Signal: Operating cash flow runs at 1.54x net income and the balance sheet carries net cash, confirming earnings quality, yet at 81.9x price-to-tangible-book and a 20% EPS decline expected in 2026, the stock offers no asset-based floor and prices in a recovery that is still two years out. Conviction: Neutrality persists because neither side of the trade is compelling — the business is too high-quality to short and too expensive to own with a margin of safety.

The Activist CatalystActivist/Capital Allocation🟢 BullishMed

Signal: A world-class franchise with 43.7% ROIC, NOK 157.5B in backlog, and a 23% pullback from the 52-week high trades at a ~25% discount to an intrinsic value range of 380–420 NOK, with NATO rearmament providing a multi-year tailwind that the market is undervaluing. Conviction: The bull case is weakened by the absence of a technical breakout — until the stock closes above 340.55 with expanding volume, the coiled range keeps this as a thesis-in-waiting rather than a confirmed reversal.

Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.

Where they agree — and where they clash

Common ground

  • All six voices agree the business quality is exceptional: 43.7% ROIC, wide moat from proprietary missile and C4ISTAR technology, net cash balance sheet, and a record NOK 157.5B backlog providing multi-year revenue visibility.
  • All six agree the stock is not cheap at 51.9x trailing earnings (33.8x forward), with the FCF yield of 2.1% comparing poorly to the 4.7% 10-year Treasury.
  • All six recognize the 304–340 technical coil as a decision point that needs a catalyst — neither side of the trade is actionable without a boundary break.
  • Defence Systems margin compression (19.6% to 17.7%) is identified by every voice as a real near-term concern that must stabilize for the backlog-conversion thesis to hold.

The real debate

  • The Activist Catalyst sees a ~25% discount to intrinsic value at 315 NOK and is willing to buy a world-class franchise at that gap. The Moat Compounder sees no margin of safety until 250–270 NOK, a difference of over 100 NOK per share on the same high-quality asset.
  • The GARP Operator accepts a PEG of 1.73 as reasonable compensation for the growth quality and backlog visibility, while The Forensic Skeptic rejects paying 33.8x forward earnings for a business facing a 20% EPS contraction in the year ahead.

The question it comes down to: Can Kongsberg convert its record backlog into margin-accretive earnings before the current premium multiple compresses, or will execution friction and a trough 2026 EPS justify a further de-rating toward the 250–304 range?

The bottom line

  • Breakout level to confirm the turn: A weekly close above 340.55 with expanding volume flips the call decisively, confirming the coil resolves upward and the Stage 2 uptrend resumes.
  • Breakdown level to monitor: A weekly close below 304.33 (the 61.8% Fibonacci) breaks the Stage 2 structure and opens a path toward the monthly EMA20 near 299, which would flip the call to SELL.
  • Next catalyst: Q3 2026 earnings (expected October 2026) must show whether Defence Systems margin stabilizes above 17% or continues compressing — this single metric is the most watched variable for validating the backlog-conversion thesis.
  • Historical accumulation zone: A pullback to 250–270 NOK would compress the forward P/E below 30x, a level where multiple cautious voices on the panel have indicated they would become buyers of the franchise.

contact@verdixhq.com · Published 2026-08-22 · Prices as of 2026-08-22 · Time horizon: 3–12 months · No direct position held in KOG · KOG verdict history → · Methodology →

Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.

Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.

Stay ahead of KOG's next verdict

The panel's view can flip on new earnings, a guidance cut, or a valuation shift. Get the update the moment it happens — not weeks later.

One email, only on a verdict change. Unsubscribe anytime.